(Q34105393)

31 July 2017

1 reference

title

Vaginal candidosis: epidemiological and etiological factors (English)

1 reference

31 July 2017

1 reference

1 reference

J Ferrer

1

1 reference

31 July 2017

publication date

1 December 2000

1 reference

International Journal of Gynecology and Obstetrics

31 July 2017

published in

1 reference

31 July 2017

volume

71 Suppl 1

1 reference

31 July 2017

page(s)

S21-7

1 reference

Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

21 January 2018

Candida vulvovaginitis

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

Vulvovaginitis due to Candida glabrata. An emerging problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

Torulopsis glabrata vaginitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

Evolving pathogens in vulvovaginal candidiasis: implications for patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

Ketoconazole in the prevention of experimental candidal vaginitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

Beta-Indoleethanol and Beta-Indolelactic Acid Production by Candida Species: Their Antibacterial and Autoantibiotic Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

Effects of minocycline and tetracycline on the vaginal yeast flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

Risk factors for vulvovaginal candidiasis: a case-control study among university students

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

21 January 2018

Candidal vulvovaginitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

Frequency and significance of drug resistance in vulvovaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

Chronic fungal vaginitis: the value of cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

Adherence of Candida albicans to human vaginal and buccal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

The epidemiology of vulvovaginal candidiasis: risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

Immunopathogenesis of recurrent vulvovaginal candidiasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

Immunoglobulin E anti-Candida antibodies and candidiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2800%2900350-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0020-7292(00)00350-7

1 reference

31 July 2017

1 reference